Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Gemalene Sunga
Affiliation
The University of Texas Health Science Center at Houston School of Dentistry
ORCID
Career Start Year
2017
Papers
12
H Index
7
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
37183412
Enhancement of Immunotherapies in Head and Neck Cancers Using Biomaterial-Based Treatment Strategies.
Tissue Eng Part C Methods
2023
37183412
Enhancement of Immunotherapies in Head and Neck Cancers Using Biomaterial-Based Treatment Strategies.
Tissue Eng Part C Methods
2023
35190203
T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients.
Hum Immunol
2022
36192241
Corrigendum to "T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients" [Hum. Immunol. 83(4) (2022) 273-280].
Hum Immunol
2022
36644348
Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor-Intolerant Patients.
Kidney Int Rep
2022
35190203
T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients.
Hum Immunol
2022
36644348
Preservation of Antiviral Immunologic Efficacy Without Alloimmunity After Switch to Belatacept in Calcineurin Inhibitor-Intolerant Patients.
Kidney Int Rep
2022
36192241
Corrigendum to "T cell senescence and impaired CMV-specific response are associated with infection risk in kidney transplant recipients" [Hum. Immunol. 83(4) (2022) 273-280].
Hum Immunol
2022
34609965
NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant.
JCI Insight
2021
34609965
NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant.
JCI Insight
2021
32571915
Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy.
Proc Natl Acad Sci U S A
2020
32571915
Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy.
Proc Natl Acad Sci U S A
2020
35121931
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44.
Nat Cancer
2020
35121931
Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44.
Nat Cancer
2020
29695840
A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells.
Mucosal Immunol
2019
30445099
Association of pro-inflammatory cytokines and monocyte subtypes in older and younger patients on clinical outcomes after mechanical circulatory support device implantation.
Hum Immunol
2019
29695840
A screen of Crohn's disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells.
Mucosal Immunol
2019
30445099
Association of pro-inflammatory cytokines and monocyte subtypes in older and younger patients on clinical outcomes after mechanical circulatory support device implantation.
Hum Immunol
2019
29707619
Differences in Proinflammatory Cytokines and Monocyte Subtypes in Older as Compared With Younger Kidney Transplant Recipients.
Transplant Direct
2018
29913200
Increased T cell immunosenescence and accelerated maturation phenotypes in older kidney transplant recipients.
Hum Immunol
2018
29707619
Differences in Proinflammatory Cytokines and Monocyte Subtypes in Older as Compared With Younger Kidney Transplant Recipients.
Transplant Direct
2018
29913200
Increased T cell immunosenescence and accelerated maturation phenotypes in older kidney transplant recipients.
Hum Immunol
2018
28829424
A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity.
J Vis Exp
2017
28829424
A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity.
J Vis Exp
2017
1 - 24 of 24
Column Actions
Search
Recommended Authors
Sarwat T Khan
Ottawa Hospital Research Institute
Career Start Year
2017
Number of shared co-authors
0
Maigan A Brusko
University of Florida
Career Start Year
2017
Number of shared co-authors
0
Ang Cui
Massachusetts Institute of Technology
Career Start Year
2013
Number of shared co-authors
1
Jinguo Chen
Center for Human Immunology
Career Start Year
2011
Number of shared co-authors
0
Davide Bedognetti
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year
2010
Number of shared co-authors
0
Gregory L Szeto
University of Maryland
Career Start Year
2010
Number of shared co-authors
0
Jianying Zhang
City of Hope National Medical Center
Career Start Year
2009
Number of shared co-authors
0
Benjamin G Vincent
UNC School of Medicine, The University of North Carolina at Chapel Hill
Career Start Year
2008
Number of shared co-authors
0
Brandon W Higgs
Translational and Clinical Data Sciences
Career Start Year
2006
Number of shared co-authors
1
Min Luo
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year
2006
Number of shared co-authors
0
Tori N Yamamoto
National Cancer Institute
Career Start Year
2005
Number of shared co-authors
0
Kristin Baird
National Cancer Institute, National Institutes of Health
Career Start Year
2004
Number of shared co-authors
0
Glenda Canderan
University of Virginia
Career Start Year
2003
Number of shared co-authors
0
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Career Start Year
2002
Number of shared co-authors
0
Martin Prlic
Fred Hutchinson Cancer Research Center
Career Start Year
2001
Number of shared co-authors
0
Sophie Paczesny
Hollings Cancer Center, Medical University of South Carolina
Career Start Year
2001
Number of shared co-authors
0
Ning Jiang
The University of Texas at Austin
Career Start Year
2000
Number of shared co-authors
5
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year
2000
Number of shared co-authors
3
David J Liewehr
Center for Cancer Research
Career Start Year
1999
Number of shared co-authors
0
Seunghee Kim-Schulze
Icahn School of Medicine at Mount Sinai
Career Start Year
1996
Number of shared co-authors
1
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Career Start Year
1995
Number of shared co-authors
2
Ping Jin
Center for Cellular Engineering, National Institutes of Health Clinical Center
Career Start Year
1993
Number of shared co-authors
0
Jonathan S Serody
The University of North Carolina School of Medicine
Career Start Year
1991
Number of shared co-authors
0
Veena Kapoor
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year
1991
Number of shared co-authors
0
Nir Hacohen
Broad Institute of MIT and Harvard
Career Start Year
1989
Number of shared co-authors
1
Martin S Zand
University of Rochester Medical Center
Career Start Year
1983
Number of shared co-authors
0
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year
1983
Number of shared co-authors
0
Paul Brent Ferrell
Vanderbilt University
Career Start Year
1981
Number of shared co-authors
0
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Career Start Year
1978
Number of shared co-authors
2
James M Reuben
The University of Texas MD Anderson Cancer Center
Career Start Year
1978
Number of shared co-authors
1
row(s) 1 - 30 of 30
Collaborators
Maura Rossetti
University of California Los Angeles
Co-authored papers
11
Joanna Schaenman
University of California los angeles
Co-authored papers
7
Elaine F Reed
University of California Los Angeles
Co-authored papers
7
Victoria Groysberg
Co-authored papers
3
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers
2
Mario C Deng
Ronald Reagan university of california los angeles Medical Center
Co-authored papers
2
Sitaram Vangala
University of California los angeles
Co-authored papers
2
David Casero
David Geffen School of Medicine, University of California los angeles
Co-authored papers
1
Jaklin Gukasyan
David Geffen School of Medicine at the University of California los angeles
Co-authored papers
1
Murray Kwon
University of California Los Angeles, David Geffen School of Medicine
Co-authored papers
1
Benjamin Bachrach
David Geffen School of Medicine at the University of California los angeles
Co-authored papers
1
Maral Bakir
David Geffen School of Medicine, university of california los angeles Medical Center
Co-authored papers
1
Steven M Dubinett
David Geffen School of Medicine at university of california los angeles
Co-authored papers
1
Eleanor Chang
David Geffen School of Medicine
Co-authored papers
1
Jonathan W Goldman
David Geffen School of Medicine at university of california los angeles
Co-authored papers
1
Aaron Lisberg
Jonsson Comprehensive Cancer Center, university of california los angeles
Co-authored papers
1
Ramnik J Xavier
Broad Institute of MIT and Harvard
Co-authored papers
1
Debory Li
David Geffen School of Medicine at the University of California los angeles
Co-authored papers
1
Alex A T Bui
Co-authored papers
1
Jesse M Zaretsky
University of California los angeles
Co-authored papers
1
Edward B Garon
David Geffen School of Medicine, University of California Los Angeles
Co-authored papers
1
Ryan Balfour Sartor
University of North Carolina at Chapel Hill
Co-authored papers
1
Frederic D Bushman
Perelman School of Medicine, University of Pennsylvania
Co-authored papers
1
Xinkai Zhou
University of California Los Angeles
Co-authored papers
1
Alexander Hoffmann
Co-authored papers
1
Zorawar S Noor
David Geffen School of Medicine at university of california los angeles
Co-authored papers
1
Galyna Bondar
Co-authored papers
1
Tristan Grogan
University of California Los Angeles
Co-authored papers
1
Curtis Huttenhower
Broad Institute of MIT and Harvard
Co-authored papers
1
Martin Cadeiras
UC Davis Medical Center
Co-authored papers
1
1 - 30